Practice question

Answer the question and get instant feedback.

HardCardiologyHeart Failure-Add-on Therapyus-abimus-usmle-step-3

A 64-year-old with HFrEF on sacubitril/valsartan, carvedilol, spironolactone, and empagliflozin remains NYHA III. BP 102/64, HR 72, K 4.6. Which therapy may reduce mortality further?

Educational content. Not a substitute for clinical judgement or local policy.